Quanterix to Participate in Barclays Global Healthcare Conference

Rhea-AI Summary

Quanterix Corporation (NASDAQ: QTRX) will have its Chairman and CEO, Kevin Hrusovsky, present at the Barclays Global Healthcare Conference on March 15, 2022, at 10:45 a.m. EST. Attendees can register for virtual participation. Hrusovsky will also conduct one-on-one meetings with institutional investors on the same day. A live webcast of his presentation will be available on the Quanterix investor relations website, with replays accessible for 90 days. Quanterix specializes in digitizing biomarker analysis to enhance precision health.

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that its Chairman and Chief Executive Officer, Kevin Hrusovsky will present in-person at the Barclays Global Healthcare Conference on March 15, 2022 at 10:45 a.m., EST. For those interested in tuning into the presentation virtually, please register here: https://cc.webcasts.com/barc002/031522a_js/?entity=34_XI7O6N4.

Hrusovsky will also host in-person one-on-one meetings with institutional investors on Tuesday, March 15. A live webcast of the conversation will be available on the investor section of the Quanterix website at https://ir.quanterix.com/investor-relations. Replays of the webcast will be available on the Quanterix website for 90 days following the conference.

About Quanterix

Quanterix is a company that’s digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Billerica, Massachusetts. For additional information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release are based on Quanterix’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause Quanterix’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in Quanterix’ filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" sections contained therein. Except as required by law, Quanterix assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005951/en/

Media:

PAN Communications

Paige Romine, 321-652-8370

pan.quanterix@pancomm.com

Investor Relations:

Stephen Hrusovsky

(774) 278-0496

shrusovsky@quanterix.com

Source: Quanterix Corporation

FAQ

When is Quanterix participating in the Barclays Global Healthcare Conference?

Quanterix will present at the Barclays Global Healthcare Conference on March 15, 2022, at 10:45 a.m. EST.

Who is presenting for Quanterix at the Barclays Global Healthcare Conference?

Kevin Hrusovsky, the Chairman and CEO of Quanterix, will be presenting at the conference.

How can I access the Quanterix presentation at the Barclays Global Healthcare Conference?

You can access the Quanterix presentation virtually by registering on their investor relations website.

Will there be a replay available for the Quanterix conference presentation?

Yes, a replay of the Quanterix presentation will be available on their website for 90 days following the conference.

What is the goal of Quanterix Corporation?

Quanterix aims to advance precision health through digitizing biomarker analysis, enabling earlier disease detection and improved treatment methods.